Tag: Avws

Essential thrombocythemia (ET), a rare myeloproliferative neoplasm, can paradoxically increase the risk of both clotting and bleeding. This counterintuitive dual risk challenges the assumption that high platelet counts always lead to increased coagulation. The key to understanding why does bleeding occur in essential thrombocythemia lies in the dysfunctional nature of the overproduced platelets and secondary clotting factor deficiencies.

While von Willebrand disease (VWD) is almost always inherited, and many with mild cases may not be diagnosed until adulthood, it is possible to develop a form of the disorder later in life as a result of other medical conditions, known as acquired von Willebrand syndrome (AVWS). Unlike its genetic counterpart, AVWS is not passed down through families.

While acquired von Willebrand disease (AVWD) is a rare bleeding disorder that develops later in life, its prognosis differs significantly from its inherited counterpart. This authoritative guide explores the possibility of a cure by answering the critical question: is acquired von Willebrand disease curable?